β-D-galactosyl-(1→4)-β-D-glucosyl-N-(docosanoyl)sphingosine

N-[(2S,3R,4E)-1-{[β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]docosanamide

QYWVASPEUXEHSY-NNRNTGNWSA-N CHEBI:62109 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: QYWVASPEUXEHSY-NNRNTGNWSA-N
InChI Key: QYWVASPEUXEHSY-NNRNTGNWSA-N
IUPAC name: N-[(2S,3R,4E)-1-{[β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]docosanamide
Preferred name: β-D-galactosyl-(1→4)-β-D-glucosyl-N-(docosanoyl)sphingosine
INN name: —
Synonym: β-lactosylceramide
ChEBI: CHEBI:62109

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii

Observed in differential profiles

Wild_type_vs_hfq